Business

U.S. FDA Issues Form-483 With 5 Observations To Lupin’s Unit-2 Injectable Manufacturing Facility At Nagpur

[ad_1]

The inspection was a pre-approval Inspection of the injectable facility, Lupin said.

[ad_2]

Source link

What is your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

You may also like

Comments are closed.

More in:Business